Denosumab, CAS 615258-40-7

Product Description: Denosumab is a human monoclonal antibody binding to, and inhibiting, the receptor activator of RANKL (TNFSF11). Denosumab can reduce the risk of vertebral, nonvertebral and hip fractures[1], also has anti-cancer activity[2].

Applications: Cancer-programmed cell death

Formula: C6404H9908N1724O2004S50

References: [1]Moen MD, et al. Denosumab: a review of its use in the treatment of postmenopausal osteoporosis. Drugs Aging. 2011;28(1):63-82./[2]Chawla S, et al. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. Lancet Oncol. 2019;20(12):1719-1729.

CAS Number: 615258-40-7

Molecular Weight: 144716.86

Compound Purity: 99.10

Research Area: Cancer

Solubility: H2O

Target: NF-κB

• SKU: MEXHY-P9958-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P9958-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated